![Neil Abdollahian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Abdollahian
No open positions remaining
Profile
Neil Abdollahian formerly worked at Ionis Pharmaceuticals, Inc., as Assistant Director from 2004 to 2005, Avanir Pharmaceuticals, Inc., as Director-Business Development from 2005 to 2007, Emerging Growth Capital Ltd., as Director-Business Development & Special Projects, Clarity Point Partners LLC, as Managing Director, Neurogen Corp., as Manager-Business Development from 2001 to 2004, Trius Therapeutics, Inc., as Vice President-Corporate Development from 2011 to 2013, Cidara Therapeutics, Inc., as Chief Business Officer from 2016 to 2021, and Boundless Bio, Inc., as Chief Business Officer from 2021 to 2025.
Mr. Abdollahian received his undergraduate degree in 1995 from George Washington University, Masters Business Admin degree from Pepperdine University, and graduate degree in 1997 from the University of New Mexico School of Medicine.
Former positions of Neil Abdollahian
| Companies | Position | End |
|---|---|---|
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 2024-12-31 |
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 2021-08-01 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Corporate Officer/Principal | 2013-11-30 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 2006-12-31 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2004-12-31 |
Training of Neil Abdollahian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Emerging Growth Capital Ltd.
 Emerging Growth Capital Ltd. Investment Banks/BrokersFinance Provides brokerage sevices | Finance |
University of New Mexico School of Medicine
 University of New Mexico School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Clarity Point Partners LLC | |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Neil Abdollahian
